Showing 5,081 - 5,100 results of 103,715 for search '(( 50 ((ns decrease) OR (mean decrease)) ) OR ( 5 ((we decrease) OR (a decrease)) ))', query time: 1.61s Refine Results
  1. 5081
  2. 5082

    S1 Data - by Richard Junior Zapata Dongo (17912565)

    Published 2025
    “…In addition, our analysis using bioinformatics indicated that ABT-199 not only targets BCL2 but also binds to the active site of all ALK mutants, it was contrasted by <i>in vitro</i> ALK kinase activity inhibition by ABT-199 (5.5 μM). This interaction was further supported by a significant decrease of ALK phosphorylation in single and combination treatment with 300nM ABT-199. …”
  3. 5083
  4. 5084
  5. 5085
  6. 5086

    S8 File - by Martha R. Smith (20410184)

    Published 2024
    “…We performed a systematic review of studies assessing the impact of exercise interventions on validated hepatic outcomes in children with NAFLD.…”
  7. 5087

    Study populations of included studies. by Martha R. Smith (20410184)

    Published 2024
    “…We performed a systematic review of studies assessing the impact of exercise interventions on validated hepatic outcomes in children with NAFLD.…”
  8. 5088

    Future research directions. by Martha R. Smith (20410184)

    Published 2024
    “…We performed a systematic review of studies assessing the impact of exercise interventions on validated hepatic outcomes in children with NAFLD.…”
  9. 5089

    PRISMA flow diagram. by Martha R. Smith (20410184)

    Published 2024
    “…We performed a systematic review of studies assessing the impact of exercise interventions on validated hepatic outcomes in children with NAFLD.…”
  10. 5090

    S9 File - by Martha R. Smith (20410184)

    Published 2024
    “…We performed a systematic review of studies assessing the impact of exercise interventions on validated hepatic outcomes in children with NAFLD.…”
  11. 5091

    S7 File - by Martha R. Smith (20410184)

    Published 2024
    “…We performed a systematic review of studies assessing the impact of exercise interventions on validated hepatic outcomes in children with NAFLD.…”
  12. 5092

    Participant characteristics of included studies. by Martha R. Smith (20410184)

    Published 2024
    “…We performed a systematic review of studies assessing the impact of exercise interventions on validated hepatic outcomes in children with NAFLD.…”
  13. 5093

    Small Open Reading Frames, Non-Coding RNAs and Repetitive Elements in <i>Bradyrhizobium japonicum</i> USDA 110 by Julia Hahn (3279486)

    Published 2016
    “…<i>coli</i>. Finally, we revealed transcription interference resulting in an antisense RNA complementary to blr1853, a gene induced in symbiosis. …”
  14. 5094
  15. 5095
  16. 5096
  17. 5097

    Treatment outcomes. by Shaghayegh Khanmohammadi (14598182)

    Published 2023
    “…The rate of local recurrence in the included studies ranged from 9.4% to 78%, and local control progression-free survival ranged from 1 to 31 months. The total QoL decreased one week after the cryoablation procedure (-3.08 [95% Confidence interval: -4.65, -1.50], p-value <0.01) but increased one month (5.69 [3.99, 7.39], p-value <0.01) and three months (3.75 [2.25, 5.24], p-value <0.01) after the procedure.…”
  18. 5098

    Quality assessment of included papers. by Shaghayegh Khanmohammadi (14598182)

    Published 2023
    “…The rate of local recurrence in the included studies ranged from 9.4% to 78%, and local control progression-free survival ranged from 1 to 31 months. The total QoL decreased one week after the cryoablation procedure (-3.08 [95% Confidence interval: -4.65, -1.50], p-value <0.01) but increased one month (5.69 [3.99, 7.39], p-value <0.01) and three months (3.75 [2.25, 5.24], p-value <0.01) after the procedure.…”
  19. 5099

    Basic characteristics of the included studies. by Shaghayegh Khanmohammadi (14598182)

    Published 2023
    “…The rate of local recurrence in the included studies ranged from 9.4% to 78%, and local control progression-free survival ranged from 1 to 31 months. The total QoL decreased one week after the cryoablation procedure (-3.08 [95% Confidence interval: -4.65, -1.50], p-value <0.01) but increased one month (5.69 [3.99, 7.39], p-value <0.01) and three months (3.75 [2.25, 5.24], p-value <0.01) after the procedure.…”
  20. 5100

    SIRT5 is a proviral factor. by Marius Walter (13775591)

    Published 2022
    “…<b>E</b>. Decrease in cell-associated viral mRNA levels in A549-ACE2 cells infected with SARS-Cov-2 for 3 days at MOI = 0.1, and treated with SIRT5 and SIRT1 inhibitors Sirt5-i and Ex-527, as shown by RT-qPCR. …”